Providence Little Company of Mary Medical Center is a hospital in Torrance, California, US. The hospital was founded by the Sisters of the Little Company of Mary, and is part of the Providence Health & Services.

There are 317 beds in Providence Little Company of Mary Medical Center.

During the past decade, Providence Little Company of Mary Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Little Company of Mary Medical Center" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "NoNO Inc." with 2 trials sponsored, "Emory University" with 1 trials sponsored and "Medtronic Neurovascular Clinical Affairs" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Little Company of Mary Medical Center" #1 collaborator was "University of Calgary" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator, "Heidelberg University" with 1 trials as a collaborator and "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Providence Little Company of Mary Medical Center" are "Coronary Artery Disease" (3 trials), "Coronary Artery Stenosis" (2 trials), "Coronary Disease" (2 trials), "Coronary Stenosis" (2 trials) and "Stroke, Acute" (2 trials). Many other conditions were trialed in "Providence Little Company of Mary Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Little Company of Mary Medical Center" are "Device" (8 trials), "Drug" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Absorb BVS" (2 trials), "Placebo" (2 trials), "XIENCE" (2 trials), "Carotid Stenting (CAS)" (1 trials) and "Carotid endarterectomy (CEA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Little Company of Mary Medical Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Providence Little Company of Mary Medical Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Providence Little Company of Mary Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Little Company of Mary Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".